During the past decade, Ospedale Nuovo Pellegrini conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Nuovo Pellegrini" #1 collaborator was "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Nuovo Pellegrini" are "Leukemia" (2 trials). Many other conditions were trialed in "Ospedale Nuovo Pellegrini" in a lesser frequency.

Most popular intervention types in "Ospedale Nuovo Pellegrini" are "Drug" (2 trials), "Procedure" (2 trials), "Radiation" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "allogeneic bone marrow transplantation" (2 trials), "autologous bone marrow transplantation" (2 trials), "busulfan" (2 trials), "cyclophosphamide" (2 trials) and "cytarabine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Nuovo Pellegrini" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ospedale Nuovo Pellegrini". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Ospedale Nuovo Pellegrini, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Nuovo Pellegrini, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".